Oryzanol Modifies High Fat Diet-Induced Obesity, Liver Gene Expression Profile, and Inflammation Response in Mice

• Published in: Journal of agricultural and food chemistry 2017-09, Vol.65 (38), p.8374-8385
• Main Authors: Wang, Long, Lin, Qinlu, Yang, Tao, Liang, Ying, Nie, Ying, Luo, Yi, Shen, Junjun, Fu, Xiangjin, Tang, Yiping, Luo, Feijun
• Format: Article
• Language: English
• Subjects: Adipocytes - drug effects; Adipocytes - metabolism; Adipose Tissue - drug effects; Adipose Tissue - metabolism; Animals; Cholesterol - metabolism; Diet, High-Fat - adverse effects; Humans; Hypolipidemic Agents - administration & dosage; Liver - drug effects; Liver - immunology; Liver - metabolism; Male; Mice; Mice, Inbred ICR; NF-kappa B - genetics; NF-kappa B - immunology; Obesity - drug therapy; Obesity - genetics; Obesity - immunology; Obesity - metabolism; Phenylpropionates - administration & dosage; Triglycerides - metabolism
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.7b03230

In Western countries and China, the dietary habit of high calories usually results in hyperlipidemia, which is closely associated with cardiovascular diseases. In the study, we investigated the antihyperlipidemic effect of oryzanol and its molecular mechanism in the high fat diet (HFD) mouse model. In total, 60 ICR mice were randomly divided into control group, HFD group, and HFD+Ory group. The mice from the HFD+Ory group were additionally fed with 100 mg/kg of oryzanol by intragastric administration. Our data indicated that oryzanol treatment for 10 weeks significantly reduced bodyweight, liver weight, and adipose tissues weight of the mice; lowered the contents of total cholesterol (TC), triglycerides (TG), and low density lipoprotein-cholesterol (LDL-C); and elevated high density lipoprotein-cholesterol (HDL-C) in the plasma of HFD mice. Compared with the HFD group, H&E staining showed that oryzanol treatment decreased the size of fat droplets of liver tissues and the size of adipocytes. Gene chip data found that oryzanol administration caused 32 genes to increase expressions while 60 genes had reduced expressions in the liver tissues of HFD mice. IPA software was used to analyze the protein interaction network and found that transcript factor NF-κB located in the central role of network, meaning NF-κB may have important function in the lipid-lowering effect of oryzanol. Western blotting and RT-qPCR confirmed that lipid metabolism-related gene expressions were obviously regulated by oryzanol administration. Oryzanol also inhibited expressions of inflammatory factor in the liver tissues of HDF mice. Taken together, our data indicate that oryzanol treatment can regulate lipid metabolism-related gene expressions and inhibit HDF-caused obesity in mice.